NCT04217798 Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer Status UNKNOWN Phase PHASE2
NCT04214964 Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study Status UNKNOWN Phase N/A
NCT04214782 Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm Status UNKNOWN Phase NA
NCT04204811 Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy Status ACTIVE_NOT_RECRUITING Phase NA
NCT04201561 High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy Status UNKNOWN Phase PHASE3
NCT04180371 Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04176484 Feasibility of Opportunistic Salpingectomy During Non-Gynecologic Surgery Status UNKNOWN Phase N/A
NCT04170712 Data and Specimen Bank of Patients Diagnosed With, and at High-risk for, Gynecologic Cancers Status UNKNOWN Phase N/A
NCT04169997 A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04163094 Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy Status TERMINATED Phase PHASE1
NCT04152018 Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. Status TERMINATED Phase PHASE1
NCT04140526 Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04122937 Defining Inflammation Related to Peritoneal Carcinomatosis in Women With Ovarian or Colon Cancer. Status COMPLETED Phase N/A
NCT04122235 The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study Status COMPLETED Phase NA
NCT04116320 Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors Status TERMINATED Phase PHASE1